The 2027 Financial Health Checklist for Cannabis Operators - Grab Your Seat for the Free Webinar Now!
The 2027 Financial Health Checklist for Cannabis Operators - Grab Your Seat for the Free Webinar Now!
Tag: CBT > DEA Cannabis Policy and Legalization | Cannabis Business Times
Subscribe
Sign In
Tag: CBT > DEA Cannabis Policy and Legalization: Page 5
Cannabis Rescheduling
31 Bipartisan House Lawmakers Urge DEA to End ‘Failed’ Cannabis Prohibition
A group of U.S. representatives sent a letter to DEA Administrator Anne Milgram calling on her agency to “recognize the merits of full descheduling.”
November 1, 2023
Tomorrow in Cannabis
The Story of My Cannabis Arrest
30 years ago, Kenneth Morrow was arrested for commercial cannabis cultivation and sale. Here he details his experience and how the legal landscape in California—and the U.S.—has evolved.
October 23, 2023
Cannabis Rescheduling
Rescheduling Cannabis: Would 1961 Drug Treaty Be a Possible Wrench?
Reclassifying cannabis to a Schedule III drug would put the U.S. in noncompliance with the international treaty Single Convention on Narcotic Drugs, 1961. Will this create a barrier for the U.S. in its scheduling review, and if so, to what extent? Historian James H. Mills weighs in.
October 5, 2023
Cannabis Industry Research
The Impacts of Cannabis Rescheduling: Panelists Weigh In During International Cannabis Bar Association Webinar
Industry legal experts Khurshid Khoja, Amber Littlejohn and Shane Pennington shared insight into what rescheduling could mean for taxes, research and federal enforcement.
September 12, 2023
Hemp Regulations in U.S.
DEA May Propose Regulations That Would Threaten the Hemp-Derived Cannabinoid Industry and Cast a Dark Cloud Over CBD Industry
The federal agency announced in early May that it plans to soon propose new rules that would classify synthetically derived cannabinoids as controlled substances and would decontrol CBD up to 0.1% THC on a weight-to-weight or weight-to-volume basis.
May 26, 2023
Videos
Cannabis Seeds Are Federally Legal: What Now?
Following the January 2022 DEA acknowledgement that cannabis seeds are federally "legal" under the 2018 Farm Bill, we attempt to clarify precisely what that means in this webinar.
February 2, 2023
Illinois
Genetics Storefront Opens Doors in Chicago After DEA Deems Cannabis Seeds Legal
MoneyTree Genetics is selling seeds and clones to the public and to Illinois cannabis businesses and patients enrolled in the state’s medical cannabis program.
January 23, 2023
Legislation and Regulation
National Industrial Hemp Council Urges FDA to Approve Hemp Seed for Animal Feed
The NIHC sent a letter to the FDA, calling for the federal agency to approve hemp seed as a viable feed alternative for livestock producers.
November 7, 2022
Top Stories
The DEA Acknowledged That Cannabis Seeds Are Legal to Sell. So, What Does That Mean for the Industry?
An official determination from the DEA could draw the cannabis genetics market into the mainstream—if that’s what breeders and growers want.
November 1, 2022
Interviews & Opinion
FDA Issues First Batch of Warning Letters to Delta-8 THC Product Manufacturers
The federal agency is warning five companies that they are marketing unapproved new drugs, misbranding their wares and unlawfully adding delta-8 THC to food products.
May 6, 2022
Compliance
Federally Approved Cannabis?
Pennsylvania-based Groff North America has begun growing DEA-approved cannabis for FDA clinical trials.
March 9, 2022
Nevada
Scottsdale Research Institute’s Sue Sisley Announced as Day 2 Keynote at Cannabis Conference 2021
Sisley will explain her journey throughout the early days of medical cannabis research—including breakthrough discoveries—and the legal battle that she endured which ended the government’s long-standing cannabis research monopoly.
August 16, 2021
Previous Page
Page 5 of 8
Next Page